FDA
approval
· 2022-08-04
FDA Approved: BUMETANIDE — Original Application (Novadoz Pharmaceuticals LLC)
Summary
FDA approves the original ANDA for bumetanide (generic) by Novadoz Pharmaceuticals LLC for use in edema associated with congestive heart failure, liver cirrhosi…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for BUMETANIDE (BUMETANIDE)